Boston, MA -- (SBWIRE) -- 06/10/2013 -- Global Market Direct's pharmaceuticals report, "Daiichi Sankyo Company, Limited - Product Pipeline Review - 2013" provides data on the Daiichi Sankyo Company, Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Daiichi Sankyo Company, Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Daiichi Sankyo Company, Limited and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- Daiichi Sankyo Company, Limited - Brief Daiichi Sankyo Company, Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Daiichi Sankyo Company, Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Daiichi Sankyo Company, Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Daiichi Sankyo Company, Limited's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Daiichi Sankyo Company, Limited's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Daiichi Sankyo Company, Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Daiichi Sankyo Company, Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Daiichi Sankyo Company, Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Daiichi Sankyo Company, Limited and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Daiichi Sankyo Company, Limited - Product Pipeline Review - 2012
- Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review
- Takeda Pharmaceutical Company Limited - Product Pipeline Review - 2013
- Type 2 Diabetes - Pipeline Review, H1 2013
- Ranbaxy Laboratories Limited (RANBAXY) - Financial and Strategic SWOT Analysis Review
- Daiichi Sankyo Company, Limited (4568) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Gram-Positive Bacterial Infections - Pipeline Review, H1 2013
- Lupin Limited - Product Pipeline Review - 2013
- Liver Cancer - Pipeline Review, H1 2013
- Non-Small Cell Lung Cancer - Pipeline Review, H1 2013